Inspiratory Muscle Training in Patients With End Stage Renal Failure
Renal Failure, Chronic Renal Insufficiency
About this trial
This is an interventional treatment trial for Renal Failure focused on measuring Renal failure, Respiratory muscles, Resistance training
Eligibility Criteria
Inclusion Criteria:
- documented chronic renal failure
- attending either haemodialysis or pre-dialysis clinic
- age 18
- English speaking
- no prior experience with inspiratory training devices.
Exclusion Criteria:
- lung collagen disorders
- renal diseases associated with autoimmune pulmonary diseases
- current pleural effusion
- pulmonary oedema
- decreased conscious level
- behavioural disturbances
- unable or refused to give consent
- taking medications that influence respiratory muscle function (e.g. steroids or cyclophosphamide)
Sites / Locations
- Royal Brisbane & Womens Hospital
Arms of the Study
Arm 1
Arm 2
Sham Comparator
Experimental
Sham inspiratory muscle training
Inspiratory muscle training
Patients in the sham group used the threshold trainer (Threshold at IMT device URES HS730, Respironics, New Jersey, Inc, Cedar Grove, NJ, USA), with the diaphragm removed.
Inspiratory muscle training will be by a threshold trainer (Threshold at IMT device URES HS730, Respironics, New Jersey, Inc, Cedar Grove, NJ, USA), a commercially available spring-loaded inspiratory muscle training device. It will be set at 40% of the subjects baseline maximal inspiratory pressure and increased by 10% each week by an unblinded assistant. All subjects were trained with these devices for 8-10 breaths, 3 times a day, everyday for 6 weeks